Definitive Contract W911SR24C0030
Award Date
8/2/24
Potential Completion Date
12/31/24
Potential Value
$9M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Siga Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10065, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. government, to Siga Technologies, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $611,265,717.00, is for the procurement and late-stage development of a smallpox antiviral drug. The contract does not have a set-aside designation and is a definitive, firm-fixed-price agreement with a period of performance ending on August...
This is a $12,549,999,847.50 Definitive Contract awarded by the U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Division on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Biomedical Advanced Research and Development Authority (BARDA) to Pfizer Inc. for the delivery of 10 million treatment courses of the oral protease inhibitor PF-07321332. This contract, which does not utilize a small business...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Roche Laboratories Inc. for the purchase of Tamiflu® (antiviral medication) for the Strategic National Stockpile. The contract is a definitive contract with a firm fixed price of $199,048,013.60 and does not have a set-aside designation. The contract was awarded on September 30, 2009 with a period of performance ending on September 29, 2011. Roche Laboratories Inc....
<p>This is a contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emergent Biodefense Operations Lansing LLC, also known as Emergent Biodefense, for the maintenance of a smallpox license. The contract is a delivery order with a firm fixed price of $38,430,000.00 and a completion date of January 31, 2019. The place of performance is located in Cambridge, Massachusetts. The contract does not have a set-aside designation.</p>
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the U.S. government. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a combat support agency of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medical products and supplies to federal agencies, particularly the DoD and Department of Veterans...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,198,891 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $3,189.12 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense responsible for providing medical supplies to military treatment facilities and other federal healthcare programs. The contract has no...
<p>This is a $98,144,230.00 definitive, cost-sharing contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to The Medicines Company on September 15, 2016. The contract is to advance the development of a portfolio of anti-infective programs. There is no set-aside designation indicated. The contract has an ultimate completion date of September 30, 2030.</p>
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,055.87 and covers the delivery of TICOVAC 2.4MCG/0.5 10S vaccine doses to support the medical supply needs of U.S. Department of Defense (DoD) healthcare facilities. The contract is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was made by the Veterinary Services agency (part of the Department of Agriculture) to Genentech USA, Inc., a foreign-owned, for-profit biotechnology company that manufactures pharmaceuticals. The award is for the delivery of Tamiflu (oseltamivir phosphate) capsules, 75 mg, with a ceiling value of $193,939.20 and a period of performance through December 31, 2020. This appears to be a delivery order issued against a larger contract vehicle, as Genentech holds several...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of TICOVAC 2.4MCG/0.5 10S, a pharmaceutical product, with a ceiling value of $6,189.60 and a period of performance through May 6, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) vehicle, valued at...